Capsida Biotherapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
59
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$70M
- Investors
-
5
Capsida Biotherapeutics General Information
Description
Developer of targeted gene therapies designed to treat debilitating and life-threatening genetic disorders in both the central nervous system and non-CNS indications. The company's therapies use an adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the diseased organ while limiting the transduction of tissues and cells not relevant to the target disease, enabling healthcare providers to have access to targeted therapies to improve patient health outcomes.
Contact Information
Website
www.capsida.comCorporate Office
- 1300 Rancho Conejo Boulevard
- Newbury Park
- Thousand Oaks, CA 91320
- United States
Corporate Office
- 1300 Rancho Conejo Boulevard
- Newbury Park
- Thousand Oaks, CA 91320
- United States
Capsida Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 23-Feb-2023 | $70M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 28-Apr-2021 | Completed | Generating Revenue | |||
| 1. Corporate | 28-Apr-2021 | $90M | $90M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Capsida Biotherapeutics Comparisons
Industry
Financing
Details
Capsida Biotherapeutics Competitors (43)
One of Capsida Biotherapeutics’s 43 competitors is Minoryx, a Venture Capital-Backed company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Minoryx | Venture Capital-Backed | Barcelona, Spain | ||||
| Vedanta Biosciences | Venture Capital-Backed | Cambridge, MA | ||||
| Priothera | Venture Capital-Backed | Dublin, Ireland | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| Sernova Biotherapeutics | Corporation | Mississauga, Canada |
Capsida Biotherapeutics Patents
Capsida Biotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026136871-A1 | Adeno-associated virus compositions having increased brain enrichment | Pending | 20-Dec-2024 | ||
| WO-2026096911-A1 | Gene therapy for friedreich's ataxia | Pending | 01-Nov-2024 | ||
| WO-2026050233-A1 | Novel adeno-associated virus compositions having increased brain enrichment | Pending | 26-Aug-2024 | ||
| WO-2025231383-A1 | Compositions and methods of delivering a therapeutic across the blood-brain barrier via the pl16 receptor | Pending | 03-May-2024 | ||
| WO-2025213066-A1 | Adeno-associated virus compositions for treating parkinson's disease (pd) | Pending | 05-Apr-2024 | A61P25/00 |
Capsida Biotherapeutics Signals
Capsida Biotherapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AbbVie Ventures | Corporate Venture Capital | Minority | ||
| AbbVie | Corporation | Minority | ||
| Versant Ventures | Venture Capital | Minority | ||
| Westlake Village BioPartners | Venture Capital | Minority | ||
| Lilly USA | Corporation |
Capsida Biotherapeutics FAQs
-
When was Capsida Biotherapeutics founded?
Capsida Biotherapeutics was founded in 2019.
-
Where is Capsida Biotherapeutics headquartered?
Capsida Biotherapeutics is headquartered in Thousand Oaks, CA.
-
What is the size of Capsida Biotherapeutics?
Capsida Biotherapeutics has 59 total employees.
-
What industry is Capsida Biotherapeutics in?
Capsida Biotherapeutics’s primary industry is Drug Discovery.
-
Is Capsida Biotherapeutics a private or public company?
Capsida Biotherapeutics is a Private company.
-
What is Capsida Biotherapeutics’s current revenue?
The current revenue for Capsida Biotherapeutics is .
-
How much funding has Capsida Biotherapeutics raised over time?
Capsida Biotherapeutics has raised $300M.
-
Who are Capsida Biotherapeutics’s investors?
AbbVie Ventures, AbbVie, Versant Ventures, Westlake Village BioPartners, and Lilly USA have invested in Capsida Biotherapeutics.
-
Who are Capsida Biotherapeutics’s competitors?
Minoryx, Vedanta Biosciences, Priothera, Sangamo Therapeutics, and Sernova Biotherapeutics are some of the 43 competitors of Capsida Biotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process